Brought to you by 
Dianon will acquire UroCor
13 Jul 2001
Executive Summary
Dianon Systems (diagnostics, genetic testing, and related information services) has agreed to purchase UroCor (urology disease management) in a tax-free transaction, issuing stock that is currently worth about $151mm. The merger will create the largest urology diagnostics provider in the US.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Dianon will acquire UroCor
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice